Silvan Tuerkcan

Stock Analyst at JMP Securities

(3.71)
# 788
Out of 5,041 analysts
174
Total ratings
48.24%
Success rate
8.18%
Average return

Stocks Rated by Silvan Tuerkcan

Terns Pharmaceuticals
Oct 23, 2025
Maintains: Market Outperform
Price Target: $20$15
Current: $7.25
Upside: +106.90%
Intellia Therapeutics
Oct 6, 2025
Upgrades: Market Outperform
Price Target: $33
Current: $25.86
Upside: +27.61%
Benitec Biopharma
Sep 24, 2025
Reiterates: Market Outperform
Price Target: $20
Current: $15.81
Upside: +26.50%
Jasper Therapeutics
Sep 22, 2025
Maintains: Market Outperform
Price Target: $12$6
Current: $2.44
Upside: +145.91%
Phreesia
Sep 8, 2025
Maintains: Market Outperform
Price Target: $30$34
Current: $23.79
Upside: +42.92%
IDEAYA Biosciences
Sep 8, 2025
Maintains: Market Outperform
Price Target: $41$45
Current: $28.64
Upside: +57.15%
Exelixis
Jul 29, 2025
Reiterates: Market Outperform
Price Target: $50
Current: $38.03
Upside: +31.48%
CRISPR Therapeutics AG
Jun 27, 2025
Reiterates: Market Outperform
Price Target: $86
Current: $67.60
Upside: +27.22%
Nuvation Bio
Jun 25, 2025
Reiterates: Market Outperform
Price Target: $6
Current: $4.56
Upside: +31.58%
Solid Biosciences
Jun 6, 2025
Reiterates: Market Outperform
Price Target: $15
Current: $5.71
Upside: +162.70%
Maintains: Market Outperform
Price Target: $5$6
Current: $4.96
Upside: +20.97%
Maintains: Market Outperform
Price Target: $10$6
Current: $5.44
Upside: +10.29%
Reiterates: Market Outperform
Price Target: $9
Current: $3.80
Upside: +136.84%
Downgrades: Market Perform
Price Target: $120
Current: $27.99
Upside: +328.72%
Reiterates: Market Outperform
Price Target: $18
Current: $7.87
Upside: +128.86%
Reiterates: Market Outperform
Price Target: $17
Current: $2.02
Upside: +741.58%
Reiterates: Market Perform
Price Target: n/a
Current: $6.16
Upside: -
Initiates: Market Outperform
Price Target: $4
Current: $1.32
Upside: +203.03%
Reiterates: Market Outperform
Price Target: $21
Current: $6.92
Upside: +203.47%
Downgrades: Market Perform
Price Target: n/a
Current: $1.85
Upside: -
Reiterates: Market Outperform
Price Target: $6
Current: $3.43
Upside: +74.92%
Maintains: Buy
Price Target: $240$280
Current: $199.10
Upside: +40.63%
Maintains: Market Outperform
Price Target: $18$18
Current: $9.86
Upside: +82.56%